CATCH-UP: NCI ETCTN Pittsburgh Cancer Consortium (PCC)

摘要 提交此申请是为了请求将附属组织(S)添加到早期 治疗学临床试验网络(ETCTN)UM1领导学术组织。 加州大学欧文分校(UCI)曹氏家庭综合癌症中心(CFCCC) 在为未得到充分服务的人创建靶向癌症治疗途径方面被证明是一个表现良好的网站 人口(追赶)计划，总共招募了34名患者，其中近一半(48%)来自不同的国家 患者群体(例如拉丁裔、亚洲人和服务不足的地区)。随着CFCCC的成功参与 为了迎头赶上，CFCCC将被整合到匹兹堡癌症联盟(PCC)，为他们的 患者参加所有ETCTN试验。 委员会将通过提供监管支持、数据协调和不良事件报告来整合CFCCC UCI调查人员领导的研究的事件和结果。此外，委员会将通过以下方式支持中华全国总商会 在ETCTN试验中发展概念和领导力。相反，CFCCC将利用他们的经验和 在急起直追计划中成功部署最佳实践，以减少PCC中未得到充分服务的患者的应计费用。

ABSTRACT This application is being submitted to request the addition of an Affiliated Organization(s) to the Early Therapeutics Clinical Trial Network (ETCTN) UM1 Lead Academic Organization. The Chao Family Comprehensive Cancer Center (CFCCC) of the University of California, Irvine (UCI) has demonstrated to be a well performing site in the Create Access to Targeted Cancer Therapy for Underserved Populations (CATCH-UP) program, enrolling a total of 34 patients with nearly half (48%) coming from diverse patient populations (e.g. Latino, Asian and underserved areas). With the success of CFCCC’s participation in CATCH-UP, CFCCC will be integrated into the Pittsburgh Cancer Consortium (PCC), providing access for their patients to all ETCTN trials. The PCC will integrate CFCCC by providing regulatory support, data coordination and reporting of adverse events and outcomes on the studies led by UCI investigators. In addition, the PCC will support CFCCC through development of concepts and leadership in ETCTN trials. Conversely, CFCCC will use their experience and success in the CATCH-UP program to deploy best practices in underserved patient accrual in the PCC.